Health Law

At the very end of the Clinton Administration, Republican Congresswoman JoAnne Emerson inserted a two-paragraph provision into the 2001 Treasury and General Government Appropriations Act. These paragraphs would become known as the Data Quality Act (as well as the Information Quality Act) and its passage represented a major victory for industries – including the tobacco and chemical industries – regulated by the federal government. More

The Trump Administration is defending the ACA’s free preventive benefit guarantee before the Supreme Court as part of its effort to exercise whole-of-government control over US policy, says Sara Rosenbaum in this Opinion. More

In a series of decisions, the US Supreme Court has severely constrained the authority of federal agencies to regulate in the interest of public… More

Health disparities—the differences in access to health care and related services as well as in health utilization and outcomes—are influenced by… More

New federal court decisions have delayed the implementation of new rules protecting health care for transgender people issued under Section 1557 of the Affordable Care Act. More

Context: Opioid treatment agreements (OTAs) are documents that clinicians present to patients when prescribing opioids that describe the risks of… More

The Supreme Court’s June 29, 2023, ruling that affirmative action in the admissions processes at Harvard College and the University of North… More

ar from keeping courts away from social controversy as promised, the Dobbs decision – and the individual state power to dictate circumstances under which patients can access myriad types of reproductive health care it unleashed – pose implications that remain unpredictable, inequitable, and heart-wrenching for patients and providers alike. More

Two recent, much-discussed decisions from federal courts in Texas—one striking down the Affordable Care Act’s requirements for insurance coverage of preventive health services, the other invalidating the US Food and Drug Administration’s approval of the abortion drug mifepristone—illustrate a deepening tension between the public health community and the courts. Both decisions are now on appeal and may not ultimately be affirmed. More

Public health is vulnerable to judicial rulings in this new conservative era. More